These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28304002)

  • 1. Influence of free drug samples on prescribing by physicians: A cross sectional survey.
    Rafique S; Sarwar W; Rashid A; Sheerin F
    J Pak Med Assoc; 2017 Mar; 67(3):465-467. PubMed ID: 28304002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physician survey of the effect of drug sample availability on physicians' behavior.
    Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
    J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doctors and drug companies: still cozy after all these years.
    Henry D
    PLoS Med; 2010 Nov; 7(11):e1000359. PubMed ID: 21072244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
    Caudill TS; Johnson MS; Rich EC; McKinney WP
    Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
    Spurling GK; Mansfield PR; Montgomery BD; Lexchin J; Doust J; Othman N; Vitry AI
    PLoS Med; 2010 Oct; 7(10):e1000352. PubMed ID: 20976098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
    Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
    Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey.
    Pinckney RG; Helminski AS; Kennedy AG; Maclean CD; Hurowitz L; Cote E
    J Gen Intern Med; 2011 Jan; 26(1):40-4. PubMed ID: 20809157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician Perceptions of Step Therapy Prescribing Requirements.
    Fischer MA; Kesselheim AS; Lu Z; Ross KM; Tessema FA; Avorn J
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1210-1224. PubMed ID: 31663459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland.
    Rischatsch M
    Eur J Health Econ; 2014 Sep; 15(7):697-708. PubMed ID: 23864366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug promotion practices: A review.
    Jacob NT
    Br J Clin Pharmacol; 2018 Aug; 84(8):1659-1667. PubMed ID: 29349812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.